1. 149 GEN-011: An ATLASTM-guided peripheral-blood derived neoantigen-specific T cell therapy designed to improve on TIL approaches. (10th December 2020) Authors: Khare, Pranay; Zope, Harshal; Perry, James; DeVault, Victoria; Reuter, Mercay; Li, Adrienne; DeOliveira, Daniel; Lam, Hubert; Jain, Manish; Flechtner, Jessica; Khare, Pranay Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 390 Emerging safety and activity data from GEN-009–101: A phase 1/2a trial of GEN-009, a neoantigen vaccine in combination with PD-1 check-point inhibitors (CPI) in advanced solid tumors. (9th November 2020) Authors: Gillison, Maura; Cohen, Roger; Twardowski, Przemyslaw; Sukari, Ammar; Johnson, Melissa; Lackner, Rudy; Davis, Thomas; DeCillis, Arthur; Hernandez, Richard; Price, Jessica; Mancini, Kevin; Shainheit, Mara; Flechtner, Jessica; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 390 Emerging safety and activity data from GEN-009–101: A phase 1/2a trial of GEN-009, a neoantigen vaccine in combination with PD-1 check-point inhibitors (CPI) in advanced solid tumors. (9th November 2020) Authors: Gillison, Maura; Cohen, Roger; Twardowski, Przemyslaw; Sukari, Ammar; Johnson, Melissa; Lackner, Rudy; Davis, Thomas; DeCillis, Arthur; Hernandez, Richard; Price, Jessica; Mancini, Kevin; Shainheit, Mara; Flechtner, Jessica; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors. (9th November 2020) Authors: Shainheit, Mara; Champagne, Devin; Santone, Gabriella; Shukor, Syukri; Bicak, Ece; Tipps, Samuel; Xue, Li; Davis, Thomas; Flechtner, Jessica Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors. (9th November 2020) Authors: Shainheit, Mara; Champagne, Devin; Santone, Gabriella; Shukor, Syukri; Bicak, Ece; Tipps, Samuel; Xue, Li; Davis, Thomas; Flechtner, Jessica Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 526 InhibigenTM-specific responses suppress anti-tumor immunity and promote tumor growth. (9th November 2020) Authors: DeVault, Victoria; Dadali, Tulin; Starobinets, Hanna; Lema, Kevin; Rinaldi, Stephanie; Odeh, Osaruese; Arnold, Julie; Sheehan, Dylan; Nguyen, Cindy; Dowal, Louisa; Flechtner, Jessica; Visintin, Alberto; Lam, Hubert Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection. Issue 4 (21st January 2019) Authors: Hook, Lauren M.; Awasthi, Sita; Dubin, Jonathan; Flechtner, Jessica; Long, Deborah; Friedman, Harvey M. Journal: Vaccine Issue: Volume 37:Issue 4(2019) Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immunoprofiling of T cell responses in melanoma patients undergoing CPI therapy. (4th November 2015) Authors: Talarico, Lee Ann; Grubaugh, Daniel; Yan, Zheng; Alami, Aula; Bodmer, Jean-Luc; Higgins, Darren E; Hodi, F Stephen; Flechtner, Jessica Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗